Stay updated with Meyka’s updates about Market Volatility!
MSMEs make up a huge part of India’s economy. Millions of small and medium businesses produce goods, employ people, and supply both local and global markets. But many of them face big roadblocks when it comes to meeting rules around certification. These rules are meant to ensure product safety, quality, and compliance. But for MSMEs,…
We’ve seen Alibaba’s stock skyrocket nearly 90% year-to-date. Many would say that’s already more than most tech names can deliver. Yet when we dig deeper, a surprising story emerges: despite the big gains, Alibaba may still be priced below what its future could be worth. Why does that matter to us as investors? Because we…
Festival Foods, a well-known grocery chain in Wisconsin, is being bought by Schnuck Markets of St. Louis. The deal covers 42 Festival Foods stores plus nine from Hometown Grocers. It will be run under a new parent, the 1939 Group, while keeping the Festival Foods brand, store names, and many of its current staff. We…
For three long years, Bromley has been at the heart of a planning battle that gripped the local community. The case was more than just about buildings or permits. It became a story of people standing firm for their town and its future. Residents, campaign groups, and officials found themselves locked in debates over what…
On September 16, 2025, Gabelli Equity Trust (NYSE: GAB) declared a quarterly cash dividend of $0.15 per share, reaffirming its commitment to a 10% annual distribution policy. This announcement comes at a time when investors are closely monitoring market trends and seeking stable income sources. The dividend, payable on September 23, 2025, to shareholders of…
In 2025, the UK pharmaceutical sector faces a significant challenge: major companies have paused or canceled nearly £2 billion in planned investments. This includes AstraZeneca halting a £200 million expansion in Cambridge, and Merck & Co. scrapping a £1 billion research hub in London. These decisions are part of a broader trend where pharmaceutical giants…
We begin with this: Wall Street just set new records. The S&P 500 and Nasdaq climbed to all-time highs. We saw investor hopes grow that the U.S. Federal Reserve may soon start easing interest rates. But as the U.S. markets surged, Asia responded more quietly. We, as global watchers, see Asian shares trading with care….
Tencent, one of China’s biggest tech companies, is planning to raise $1 billion through its first-ever Dim Sum bond issue. This is not just another fund-raising event. It marks a new step for the company and for China’s efforts to expand the use of its currency outside the mainland. Dim Sum bonds are yuan-denominated bonds…
Sigachi Industries, a Hyderabad-based small-cap pharmaceutical company, has experienced a remarkable surge in its stock price, soaring nearly 37% over just two trading sessions. This unexpected rally has captured the attention of investors and market analysts alike. While such sharp increases are often attributed to company-specific developments, this particular spike has raised questions about the…
Asian markets are on fire right now. We’re seeing Japan, South Korea, Taiwan, and others hit record highs. Why? Hopes are growing that the U.S. Federal Reserve will cut interest rates soon. Investors are breathing easier. Softer U.S. inflation and signs of a cooling jobs market suggest the Fed might ease its tight stance. That…